Salavati, Ali http://orcid.org/0000-0002-1909-6175
Gencturk, Mehmet
Koksel, Yasemin
Schik, Allyssa N.
Carroll, Peter R.
Feng, Felix Y.
Rowe, Steven P.
Lawhn-Heath, Courtney
Hope, Thomas A.
Froelich, Jerry W.
Funding for this research was provided by:
RSNA Research and Education Foundation (RR1963)
Article History
Received: 3 January 2021
Accepted: 12 May 2021
First Online: 6 June 2021
Declarations
:
: This retrospective chart review study involving human participants was in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The Human Investigation Committee (IRB) of University of California, San Francisco, and University of Minnesota approved this study.
: Informed consent was waived by the local Ethics Committee of University of California, San Francisco, and University of Minnesota in view of the retrospective nature of the study, and all the procedures being performed were part of the routine care.
: Not applicable.
: Ali Salavati, Mehmet Gencturk, Yasemin Koksel, Allyssa N. Schick, Steven P. Rowe, Courtney Lawhn-Heath, Jerry W. Froelich have no conflicts of interest to declare that are relevant to the content of this article. Thomas A. Hope served as a consultant toCurium and ITM and received research funding from Clovis and Philips. Thomas A. Hope also served on scientific advisory boards for Blue Earth, Ipsen. Peter R. Carroll served on an advisory board for Progenics. Felix Y. Feng has served as a consultant to Astellas, Bayer, Blue Earth, BMS, Exact Sciences, Foundation Medicine, Janssen, Myovant, Roivant, and Varian. Felix Y. Feng also serves on the scientifc advisoy boards of SerImmune and BlueStar Genomics.